(Q67486309)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1311624%20AND%20SRC:MED&resulttype=core&format=json

14 September 2019

title

Organic delusional syndrome associated with tamoxifen treatment (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1311624%20AND%20SRC:MED&resulttype=core&format=json

14 September 2019

1 reference

1 reference

1 reference

10.1002/1097-0142(19920315)69:6<1415::AID-CNCR2820690618>3.0.CO;2-H

https://api.crossref.org/works/10.1002/1097-0142(19920315)69:6%3C1415::AID-CNCR2820690618%3E3.0.CO;2-H

2 December 2023

1 reference

10.1002/1097-0142(19920315)69:6<1415::AID-CNCR2820690618>3.0.CO;2-H

https://api.crossref.org/works/10.1002/1097-0142(19920315)69:6%3C1415::AID-CNCR2820690618%3E3.0.CO;2-H

2 December 2023

author name string

I. G. Ron

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1311624

11 September 2022

M. J. Inbar

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1311624

11 September 2022

Y. Barak

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1311624

11 September 2022

S. Stier

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1311624

11 September 2022

S. Chaitchik

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1311624

11 September 2022

language of work or name

English

0 references

publication date

1 March 1992

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1311624%20AND%20SRC:MED&resulttype=core&format=json

14 September 2019

15 March 1992

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1311624

full work available at URL

11 September 2022

number of pages

3

1 reference

based on heuristic

inferred from page(s)

https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/1097-0142%2819920315%2969%3A6%3C1415%3A%3AAID-CNCR2820690618%3E3.0.CO%3B2-H

file format

Portable Document Format

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1311624

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2F1097-0142(19920315)69:6%3C1415::AID-CNCR2820690618%3E3.0.CO;2-H

2 December 2023

1 reference

10.1002/1097-0142(19920315)69:6<1415::AID-CNCR2820690618>3.0.CO;2-H

https://api.crossref.org/works/10.1002/1097-0142(19920315)69:6%3C1415::AID-CNCR2820690618%3E3.0.CO;2-H

https://onlinelibrary.wiley.com/doi/full/10.1002/1097-0142(19920315)69:6%3C1415::AID-CNCR2820690618%3E3.0.CO;2-H

2 December 2023

1 reference

10.1002/1097-0142(19920315)69:6<1415::AID-CNCR2820690618>3.0.CO;2-H

https://api.crossref.org/works/10.1002/1097-0142(19920315)69:6%3C1415::AID-CNCR2820690618%3E3.0.CO;2-H

2 December 2023

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1311624%20AND%20SRC:MED&resulttype=core&format=json

14 September 2019

volume

69

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1311624%20AND%20SRC:MED&resulttype=core&format=json

14 September 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1311624%20AND%20SRC:MED&resulttype=core&format=json

14 September 2019

page(s)

1415-1417

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1311624%20AND%20SRC:MED&resulttype=core&format=json

Tamoxifen in advanced breast cancer

14 September 2019

cites work

1

1 reference

10.1002/1097-0142(19920315)69:6<1415::AID-CNCR2820690618>3.0.CO;2-H

https://api.crossref.org/works/10.1002/1097-0142(19920315)69:6%3C1415::AID-CNCR2820690618%3E3.0.CO;2-H

2 December 2023

Cancer clinical trials

3

21

141

Peterson

1980

1 reference

10.1002/1097-0142(19920315)69:6<1415::AID-CNCR2820690618>3.0.CO;2-H

https://api.crossref.org/works/10.1002/1097-0142(19920315)69:6%3C1415::AID-CNCR2820690618%3E3.0.CO;2-H

Hexamethylmelamine (NSC-13875) alone and in combination with 5-(3, 3-dimethyl-triazeno) imidazole-4-carboxamide (NSC-45388) in the treatment of advanced cancer

2 December 2023

4

1 reference

10.1002/1097-0142(19920315)69:6<1415::AID-CNCR2820690618>3.0.CO;2-H

https://api.crossref.org/works/10.1002/1097-0142(19920315)69:6%3C1415::AID-CNCR2820690618%3E3.0.CO;2-H

Cancer chemotherapy reports

2 December 2023

6

55

281

Kingra

1971

1 reference

10.1002/1097-0142(19920315)69:6<1415::AID-CNCR2820690618>3.0.CO;2-H

https://api.crossref.org/works/10.1002/1097-0142(19920315)69:6%3C1415::AID-CNCR2820690618%3E3.0.CO;2-H

Treatment of grade III and IV astrocytoma with dimethyl triazeno imidazole carboxamide (DTIC, NSC-45388) alone and in combination with CCNU (NSC-79037) or methyl CCNU (MeCCNU, NSC-95441)

2 December 2023

7

1 reference

10.1002/1097-0142(19920315)69:6<1415::AID-CNCR2820690618>3.0.CO;2-H

https://api.crossref.org/works/10.1002/1097-0142(19920315)69:6%3C1415::AID-CNCR2820690618%3E3.0.CO;2-H

Cancer chemotherapy reports

2 December 2023

8

54

471

Moertel

1970

1 reference

10.1002/1097-0142(19920315)69:6<1415::AID-CNCR2820690618>3.0.CO;2-H

https://api.crossref.org/works/10.1002/1097-0142(19920315)69:6%3C1415::AID-CNCR2820690618%3E3.0.CO;2-H

Leukoencephalopathy following the administration of methotrexate into the cerebrospinal fluid in the treatment of primary brain tumors

2 December 2023

9

1 reference

10.1002/1097-0142(19920315)69:6<1415::AID-CNCR2820690618>3.0.CO;2-H

https://api.crossref.org/works/10.1002/1097-0142(19920315)69:6%3C1415::AID-CNCR2820690618%3E3.0.CO;2-H

Floxuridine and its influence on postnatal cerebellar development

2 December 2023

10

1 reference

10.1002/1097-0142(19920315)69:6<1415::AID-CNCR2820690618>3.0.CO;2-H

https://api.crossref.org/works/10.1002/1097-0142(19920315)69:6%3C1415::AID-CNCR2820690618%3E3.0.CO;2-H

Taratogenic effects of the pyrimidine analogues 5-iododeoxyuridine and cytosine arabinoside in late fetal mice and rats

2 December 2023

11

1 reference

10.1002/1097-0142(19920315)69:6<1415::AID-CNCR2820690618>3.0.CO;2-H

https://api.crossref.org/works/10.1002/1097-0142(19920315)69:6%3C1415::AID-CNCR2820690618%3E3.0.CO;2-H

Dysmetabolic and Neurological Complications in Leukemic Patients Treated with L-Asparaginase

2 December 2023

15

1 reference

10.1002/1097-0142(19920315)69:6<1415::AID-CNCR2820690618>3.0.CO;2-H

https://api.crossref.org/works/10.1002/1097-0142(19920315)69:6%3C1415::AID-CNCR2820690618%3E3.0.CO;2-H

Psychiatric complications of long-term interferon alfa therapy

2 December 2023

16

1 reference

10.1002/1097-0142(19920315)69:6<1415::AID-CNCR2820690618>3.0.CO;2-H

https://api.crossref.org/works/10.1002/1097-0142(19920315)69:6%3C1415::AID-CNCR2820690618%3E3.0.CO;2-H

Acute adverse reactions to prednisone in relation to dosage

2 December 2023

18

1 reference

10.1002/1097-0142(19920315)69:6<1415::AID-CNCR2820690618>3.0.CO;2-H

https://api.crossref.org/works/10.1002/1097-0142(19920315)69:6%3C1415::AID-CNCR2820690618%3E3.0.CO;2-H

Tamoxifen (antiestrogen) therapy in advanced breast cancer

2 December 2023

20

1 reference

10.1002/1097-0142(19920315)69:6<1415::AID-CNCR2820690618>3.0.CO;2-H

https://api.crossref.org/works/10.1002/1097-0142(19920315)69:6%3C1415::AID-CNCR2820690618%3E3.0.CO;2-H

2 December 2023

Identifiers

10.1002/1097-0142(19920315)69:6<1415::AID-CNCR2820690618>3.0.CO;2-H

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1311624%20AND%20SRC:MED&resulttype=core&format=json

14 September 2019

1 reference